203 related articles for article (PubMed ID: 8964407)
1. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup.
Vasiliauskas EA; Plevy SE; Landers CJ; Binder SW; Ferguson DM; Yang H; Rotter JI; Vidrich A; Targan SR
Gastroenterology; 1996 Jun; 110(6):1810-9. PubMed ID: 8964407
[TBL] [Abstract][Full Text] [Related]
2. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease].
García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J
Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176
[TBL] [Abstract][Full Text] [Related]
3. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease.
Satsangi J; Landers CJ; Welsh KI; Koss K; Targan S; Jewell DP
Inflamm Bowel Dis; 1998 Feb; 4(1):18-26. PubMed ID: 9552224
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis.
Preda CM; Vermeire S; Rutgeerts P; Joosens S; Diculescu M; Marica C; Ciocarlan M; Mirea V; Oproiu A
Rom J Gastroenterol; 2005 Dec; 14(4):357-60. PubMed ID: 16400351
[TBL] [Abstract][Full Text] [Related]
5. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease.
Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL
Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819
[TBL] [Abstract][Full Text] [Related]
6. [Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease].
Gisbert JP; Luna M; Legido J; Hermida C; Maté J; Pajares JM
Med Clin (Barc); 2004 Feb; 122(4):134-5. PubMed ID: 14967094
[TBL] [Abstract][Full Text] [Related]
7. Atypical perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease.
Freeman HJ
Can J Gastroenterol; 1997; 11(8):689-93. PubMed ID: 9459049
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study.
Ooi CJ; Lim BL; Cheong WK; Ling AE; Ng HS
Ann Acad Med Singap; 2000 Nov; 29(6):704-7. PubMed ID: 11269973
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value.
Homsak E; Micetić-Turk D; Bozic B
Wien Klin Wochenschr; 2010 May; 122 Suppl 2():19-25. PubMed ID: 20517666
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
11. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
[TBL] [Abstract][Full Text] [Related]
12. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.
Olives JP; Breton A; Hugot JP; Oksman F; Johannet C; Ghisolfi J; Navarro J; Cézard JP
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):142-8. PubMed ID: 9252899
[TBL] [Abstract][Full Text] [Related]
14. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.
Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH
Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
16. ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation.
Abu-Freha N; Badarna W; Sigal-Batikoff I; Abu Tailakh M; Etzion O; Elkrinawi J; Segal A; Mushkalo A; Fich A
BMC Gastroenterol; 2018 Oct; 18(1):153. PubMed ID: 30342474
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
Bansi DS; Chapman RW; Fleming KA
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M
Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
20. Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease.
Klebl FH; Bataille F; Bertea CR; Herfarth H; Hofstädter F; Schölmerich J; Rogler G
Inflamm Bowel Dis; 2003 Sep; 9(5):302-7. PubMed ID: 14555913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
